Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery

NCT04922333 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT04922333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 3
Overall status
Recruiting
Start date
March 28, 2023
Completion date
April 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss